What's on Your Mind?

A college degree is usually thought of as a ticket to a great job and a secure future. Yet, the job market over the past few years has not been kind to graduates. Rapid changes in technology and uncertainty about the influence of AI on the economy have made it harder for companies to know what their new employees need to know to be successful. I have argued in the past that this uncertainty actually makes college degrees more useful than ever, but higher education is doing a poor job of helping students navigate this uncertainty. Sadly, universities aren’t going to fix this problem by hiring more career counselors. Instead, they’re going to have to do the hard work of…

There were a lot of smiling faces at the Oscars but one had to stand out—Sean Baker saw his film Anora go home with the top film prize and he took four for himself. Its star Mikey Madison was crowned best actress. Twenty-two years after winning best actor for The Pianist, Adrien Brody won the same Oscar again for his performance as another Holocaust survivor in Brady Corbet’s The Brutalist. He somehow kept the playoff music at bay. On Sunday, firefighters who battled recent wildfires got applauded, Mick Jagger handed out the best original song Oscar, and John Lithgow was tasked with looking “slightly disappointed” when speeches ran long. One highlight was Timothée Chala…

This Oscar cycle’s heavyweight battle is finally over. The politically charged action comedy “One Battle After Another” just managed to outmuscle Ryan Coogler’s musically driven vampire thriller “Sinners.” It was a 3 hour and 40 minute whirl through cinema and celebration, with Michael B. Jordan winning best actor for “Sinners” and Jessie Buckley winning for “Hamnet,” making her the first Irish performer to ever win in the category. There was electricity when Autumn Durald Arkapaw became the first woman and Black person to win the cinematography award for “Sinners,” asking all the women in the Dolby Theatre to stand up because moments like this don’t happen without wome…

Telehealth company Hims & Hers Health is fighting back after the drug industry’s main lobbying group called out its first Super Bowl ad as “misleading” and in potential violation of marketing rules. The ad is a one-minute spot set to Childish Gambino’s “This is America,” which admonishes the U.S.’s “broken” weight-loss business and instead offers up its “affordable, doctor-trusted” copycat weight-loss drugs. The lobbying group, Pharmaceutical Research and Manufacturers of America, said Thursday the ad was “a clear violation” of the Federal Food, Drug, and Cosmetic Act and “misrepresents the safety and efficacy of their knockoff GLP-1 medicines.” Hims &…

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug and one day after the Food and Drug Administration threatened to restrict access to the ingredients needed to copy popular weight-loss medications. Hims had said Thursday that it would offer a compounded version of the new Wegovy pill that drugmaker Novo Nordisk just began selling last month. Novo immediately threatened to sue Hims, and then the FDA said Friday that it plans to take decisive steps to limit access to the active ingredients in popular GLP-1 drugs like Wegovy, Ozempic and Zepbound. Hims’ own w…

Shares in Hims & Hers Health (NYSE: HIMS) are soaring this morning after an unconfirmed report that the telehealth company is entering into a deal with Novo Nordisk A/S (NYSE: NVO) to sell its popular GLP-1 weight-loss drugs, including Wegovy. The rumored deal is as surprising as Hims & Hers’s surging stock price this morning, especially considering that just last month, Novo was threatening to sue the telehealth provider. Here’s what you need to know. What’s happened? Late on Friday, Bloomberg reported that Hims & Hers has reached an agreement with the Danish drugmaker Novo Nordisk to sell Novo’s weight-loss drugs, including the popular GLP-1 pill…

Shares in Hims & Hers Health, Inc. (NYSE: HIMS) are skyrocketing in early-morning trading today after the telehealth company announced a new partnership with the Danish pharmaceutical giant Novo Nordisk. That partnership will see Hims & Hers offer Novo Nordisk’s weight-loss drug Wegovy through its platform. Here’s what you need to know. Hims & Hers will offer weight-loss drug Wegovy Hims & Hers Health announced today that it has entered into “a long-term collaboration” with Danish drugmaker Novo Nordisk to offer its popular weight-loss drug Wegovy to its users through the Hims & Hers platform. The news sent HIMS shares soaring in early-morn…

Amid a month of skyrocketing stock prices and unprecedented social media buzz, Hims & Hers is expanding its territory into at-home blood testing and diagnostics. Hims has acquired at-home lab testing facility Trybe Labs, the telehealth company said Wednesday. Using at-home blood draws, Hims will now offer over 70 at-home diagnostics tests, ranging from heart health to certain cancer detection tests. All these can be arranged through the app, without a doctor’s visit. “At-home lab testing is one more exciting step towards elevating the personal, comprehensive care customers in this country should expect,” Dr. Patrick Carroll, Hims & Hers chief medical o…

Hinge Health Inc, the digital physical therapy health startup that is expected to make its market debut on Thursday, in a closely watched initial public offering (IPO) that will test the market’s interest for a new digital health offering, after what has been a challenging few years for the sector. Recently, there have been fewer tech IPOs, but they could be making a comeback, according to CNBC. The San Francisco-based company priced shares at $32 on Wednesday, the higher end of its expected range, in an offering led by Morgan Stanley, Barclays, and BofA Securities. The stock will list on the New York Stock Exchange (NYSE) under the “HNGE” ticker symbol. Bas…

There was a time when artists representing two of America’s biggest homegrown musical genres wouldn’t get a look in at the Grammys. Hip-hop and house both have their origins in the 1970s and early 1980s—in fact, they recently celebrated a 50th and 40th birthday, respectively. But it was only in 1989 that an award category for “best rap performance” started recognizing hip-hop’s contribution to U.S. music, and house had to wait another decade, with the introduction of “best dance/electronic recording” in 1998. At this year’s awards, taking place on February 2, hip-hop and house artists will be among the most talked about. House duo Justice and Kendrick Lamar, a hip…

Hiroshi Fujiwara is perhaps the most dramatically lit person I’ve ever interviewed on Zoom. Joining me at his preferred time (midnight) from Tokyo, the man known as the godfather of streetwear—who launched his own label at 26, was among the first hip-hop DJs in Japan, wrote a regular column for Popeye, and now runs his own consultancy, Fragment—has met with me to discuss his latest collaborations with Nike. But when I dig in, asking about the hidden details lurking in his shoes? He admits, “I don’t really want to talk about it,” without an ounce of rudeness. “Sometimes, if you see a movie and you don’t really get the ending, you have to guess what [the creators] t…

Hit-Boy has made chart-topping beats for the likes of Beyoncé, Jay Z, Nas and Doechii but behind the scenes he was stuck in a restrictive publishing deal. In this interview, Hit-Boy talks But now he’s in full control of his art and his story. He’ll also dive into his creative process and how he’s walking the line of AI and art. View the full article

During the week of Christmas, the Food and Drug Administration (FDA) has announced food recalls for several holiday treats. Before you begin enjoying your holiday snacks, it’s a good idea to check whether any of the goodies you have at home were recently recalled. Here’s what you need to know. The following food products are part of recent food recalls: ​Atwater’s cookie tins Choceur cookie butter holiday bark Choceur pecan, cranberry and cinnamon holiday park Troemner Family Farm Pfeffernusse Cookies You can find more details about each product recall below. Atwater’s cookie tins On December 22, 2025, Baltimore-based Atwater’s recalled…

A new campaign launches today against AI’s sticky fingers on copyrighted material. The Human Artistry Campaign’s “Stealing Isn’t Innovation” movement launches today with over 800 signatories. Those include many Hollywood actors, including Scarlett Johansson, Cate Blanchett, and Joseph Gordon-Levitt, as well as writers such as Jodi Picoult and Roxane Gay, and musicians like Cyndi Lauper and They Might be Giants. The campaign has a simple message: “Stealing our work is not innovation. It’s not progress. It’s theft—plain and simple.” Many record labels, news outlets, and other creative entities have partnered with AI companies in recent years, despite—or possib…

At first glance, it could be the trailer for a new Hollywood blockbuster starring Brad Pitt and Tom Cruise. “This was a 2 line prompt in seedance 2,” Irish filmmaker Ruairí Robinson clarifies in a caption on X of the 15-second clip, which shows two of the industry’s biggest stars locked in a fistfight on a crumbling rooftop, complete with sweeping camera angles and crisp sound effects. This was a 2 line prompt in seedance 2. If the hollywood is cooked guys are right maybe the hollywood is cooked guys are cooked too idk. pic.twitter.com/dNTyLUIwAV — Ruairi Robinson (@RuairiRobinson) February 11, 2026 The viral AI-generated clip has garnered more than 1.8 milli…

April is off to a bruising start for people working in Hollywood. Since the month began, two major studios and one of Hollywood’s most high-profile production companies have announced layoffs totaling more than 1,000 jobs combined. The job cuts come at a time of great volatility in the movie and television industry, which is facing disruption from AI while also experiencing a rapidly changing business landscape and consolidation. Here’s what you need to know. Bad Robot to cut jobs as it leaves L.A. for New York The April layoffs began with an unexpected announcement from one of Hollywood’s most successful and high-profile production companies. On April 2, Vari…

More than a thousand movie stars, writers, directors, and other Hollywood professionals announced their “unequivocal opposition” to the proposed Paramount merger with Warner Bros. Discovery in an open letter published Monday. A large swath of the movie industry, including Denis Villeneuve, Kristen Stewart, J.J. Abrams, and Joaquin Phoenix came out forcefully against the $111 billion deal that would consolidate two legacy studios into one, arguing that it further reduce jobs and movies in an already downsized Hollywood. “The result will be fewer opportunities for creators, fewer jobs across the production ecosystem, higher costs, and less choice for audiences in th…